Exploring the Relationship Between Schizophrenia and Cardiovascular Disease: A Genetic Correlation and Multivariable Mendelian Randomization Study

Autor: Karin J. H. Verweij, Rafik Tadros, Jentien M Vermeulen, Robyn E Wootton, Damiaan Denys, Eleanor Sanderson, Abdel Abdellaoui, Connie R. Bezzina, Marcus R. Munafò, Jorien L. Treur, Rada R Veeneman
Přispěvatelé: Adult Psychiatry, APH - Mental Health, ANS - Complex Trait Genetics, ANS - Compulsivity, Impulsivity & Attention, ANS - Mood, Anxiety, Psychosis, Stress & Sleep, Cardiology, ACS - Heart failure & arrhythmias, ANS - Amsterdam Neuroscience
Rok vydání: 2021
Předmět:
Zdroj: Schizophrenia bulletin, 48(2), 463-473. Oxford University Press
Veeneman, R R, Vermeulen, J M, Abdellaoui, A, Sanderson, E C M, Wootton, R E, Tadros, R, Bezzina, C R, Denys, D, Munafo, M R, Verweij, K J H & Treur, J L 2021, ' Exploring the Relationship Between Schizophrenia and Cardiovascular Disease : A Genetic Correlation and Multivariable Mendelian Randomization Study ', Schizophrenia Bulletin . https://doi.org/10.1093/schbul/sbab132
ISSN: 1745-1701
0586-7614
Popis: ImportanceIndividuals with schizophrenia have a reduced life-expectancy compared to the general population, largely due to an increased risk of cardiovascular disease (CVD). Clinical and epidemiological studies have been unable to fully unravel the nature of this relationship.ObjectiveInvestigate genetic correlations and potential bi-directional effects between liability to schizophrenia and CVD.Design, setting, and participantsWe obtained summary-data of genome-wide-association studies of schizophrenia (N=130,644), heart failure (N=977,323), coronary artery disease (N=332,477), systolic and diastolic blood pressure (N=757,601), heart rate variability (N=46,952), QT interval (N=103,331), early repolarization and dilated cardiomyopathy ECG patterns (N=63,700). We computed genetic correlations with linkage disequilibrium score regression and conducted bi-directional Mendelian randomization (MR). With multivariable MR, we investigated whether associations were mediated by smoking, body mass index, physical activity, lipid levels, or type 2 diabetes. To ensure robustness, we applied a range of sensitivity methods.Main outcomes and measuresSchizophrenia, heart failure, coronary artery disease, systolic blood pressure, diastolic blood pressure, heart rate variability, QT interval, early repolarization, dilated cardiomyopathy.ResultsGenetic correlations between liability to schizophrenia and CVD were close to zero (−0.02 to 0.04). With MR, we found robust evidence that liability to schizophrenia increases heart failure risk. This effect remained consistent with multivariable MR. There was also evidence that liability to schizophrenia increases early repolarization risk, largely mediated by BMI and lipid levels. Finally, there was evidence that liability to schizophrenia increases heart rate variability, a direction of effect contrasting previous studies. In the other direction, there was weak evidence that higher systolic, but not diastolic, blood pressure increases schizophrenia risk.Conclusions and relevanceOur findings indicate that liability to schizophrenia increases the risk of heart failure, and that this is not mediated by key health behaviours. This is consistent with the notion that schizophrenia is characterised by a systemic dysregulation of the body (including inflammation and oxidative stress) with detrimental effects on the heart. To decrease cardiovascular mortality among schizophrenia patients, priority should lie with optimal treatment and interventions in early stages of psychoses. We also identified early repolarization, currently understudied, as a potential CVD marker among patients with schizophrenia.
Databáze: OpenAIRE
Externí odkaz: